Michelle Mitchell: The work we’ve been conducting across our EDI priorities

Michelle Mitchell shared a post on LinkedIn:

“Three years ago, Cancer Research UK (CRUK) launched an Equality, Diversity and Inclusion (EDI) strategy – today I share an update on our progress to date. Read the article to see what work we’ve been conducting across our EDI priorities – cancer inequalities, research, our people and governance, leadership and engagement – and what our focus is for the future.”

Source: Michelle Mitchell/LinkedIn

Michelle Mitchell is the first female chief executive of Cancer Research UK (CRUK), the world’s leading charitable funder of cancer research. In 2021/22 the charity had an income of £668m, spent £443m on cancer research and had approximately 4,000 staff and over 30,000 volunteers. Before joining Cancer Research UK, Michelle was CEO of the MS Society for five years and a founding member of the Progressive MS Alliance: a global scientific and research joint venture and launched the STOP MS £100m appeal. Prior to that, she was Director General at Age UK, the UK’s largest older people’s charity where she worked for nearly a decade and was at the forefront of national debates on health, care and welfare. Mitchell was appointed Order of the British Empire (OBE) in the 2016 New Year Honours for services to Older People and the Voluntary Sector. She was named by Cranfield University as one of the 100 Women to Watch in 2018.